Sustained Improvement in Cognitive Processing Speed in Multiple Sclerosis Patients Completing 18 Months of Ozanimod Treatment: Results From the Phase 3 SUNBEAM Trial
MULTIPLE SCLEROSIS JOURNAL(2019)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined